Trial intelligence / Profile preview

Treatment of Menorrhagia in Women With Bleeding Disorders

NCT00111215Phase 4Completed

Sponsor
Centers for Disease Control and Prevention
Start
Jan 2001
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial in Menorrhagia comparing Desmopressin Sequence with Tranexamic Acid Sequence (2 arms). Primary endpoints: Reduction of menstrual blood loss and Quality of Life. Started Jan 2001; status: completed.

02

Drugs

tranexamic aciddesmopressin
03

Conditions

Menorrhagia

Beyond the preview

Go deeper on NCT00111215.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00111215.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call